This article was originally published in The Tan Sheet
FDA announces availability of industry guidance entitled "SUPAC-IR/MR: Immediate Release and Modified Release Solid Oral Dosage Forms, Manufacturing Equipment and Addendum." The guidance for NDA and ANDA sponsors who "wish to change equipment during the postapproval period" is available at www.fda.gov/cder/guidance/index.htm
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC